Safety and efficacy of treating symptomatic, partial-thickness rotator cuff tears with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated at the point of care: a prospective, randomized, controlled first-in-human pilot study
Background This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated from lipoaspirate at the point of care is safe and more effective than cortic...
Saved in:
| Published in | Journal of orthopaedic surgery and research Vol. 15; no. 1; pp. 122 - 18 |
|---|---|
| Main Authors | , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
30.03.2020
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1749-799X 1749-799X |
| DOI | 10.1186/s13018-020-01631-8 |
Cover
| Abstract | Background
This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated from lipoaspirate at the point of care is safe and more effective than corticosteroid injection.
Methods
Subjects aged between 30 and 75 years with sPTRCT who did not respond to physical therapy treatments for at least 6 weeks were randomly assigned to receive a single injection of an average 11.4 × 10
6
UA-ADRCs (in 5 mL liquid; mean cell viability: 88%) (
n
= 11; modified intention-to-treat (mITT) population) or a single injection of 80 mg of methylprednisolone (40 mg/mL; 2 mL) plus 3 mL of 0.25% bupivacaine (
n
= 5; mITT population), respectively. Safety and efficacy were assessed using the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES), RAND Short Form-36 Health Survey, and pain visual analogue scale (VAS) at baseline (BL) as well as 3 weeks (W3), W6, W9, W12, W24, W32, W40, and W52 post treatment. Fat-saturated T2-weighted magnetic resonance imaging of the shoulder was performed at BL as well as at W24 and W52 post treatment.
Results
No severe adverse events related to the injection of UA-ADRCs were observed in the 12 months post treatment. The risks connected with treatment of sPTRCT with UA-ADRCs were not greater than those connected with treatment of sPTRCT with corticosteroid injection. However, one subject in the corticosteroid group developed a full rotator cuff tear during the course of this pilot study. Despite the small number of subjects in this pilot study, those in the UA-ADRCs group showed statistically significantly higher mean ASES total scores at W24 and W52 post treatment than those in the corticosteroid group (
p
< 0.05).
Discussion
This pilot study suggests that the use of UA-ADRCs in subjects with sPTRCT is safe and leads to improved shoulder function without adverse effects. To verify the results of this initial safety and feasibility pilot study in a larger patient population, a randomized controlled trial on 246 patients suffering from sPTRCT is currently ongoing.
Trial registration
Clinicaltrials.gov
ID NCT02918136. Registered September 28, 2016,
https://clinicaltrials.gov/ct2/show/NCT02918136
.
Level of evidence
Level I; prospective, randomized, controlled trial. |
|---|---|
| AbstractList | This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated from lipoaspirate at the point of care is safe and more effective than corticosteroid injection.
Subjects aged between 30 and 75 years with sPTRCT who did not respond to physical therapy treatments for at least 6 weeks were randomly assigned to receive a single injection of an average 11.4 × 10
UA-ADRCs (in 5 mL liquid; mean cell viability: 88%) (n = 11; modified intention-to-treat (mITT) population) or a single injection of 80 mg of methylprednisolone (40 mg/mL; 2 mL) plus 3 mL of 0.25% bupivacaine (n = 5; mITT population), respectively. Safety and efficacy were assessed using the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES), RAND Short Form-36 Health Survey, and pain visual analogue scale (VAS) at baseline (BL) as well as 3 weeks (W3), W6, W9, W12, W24, W32, W40, and W52 post treatment. Fat-saturated T2-weighted magnetic resonance imaging of the shoulder was performed at BL as well as at W24 and W52 post treatment.
No severe adverse events related to the injection of UA-ADRCs were observed in the 12 months post treatment. The risks connected with treatment of sPTRCT with UA-ADRCs were not greater than those connected with treatment of sPTRCT with corticosteroid injection. However, one subject in the corticosteroid group developed a full rotator cuff tear during the course of this pilot study. Despite the small number of subjects in this pilot study, those in the UA-ADRCs group showed statistically significantly higher mean ASES total scores at W24 and W52 post treatment than those in the corticosteroid group (p < 0.05).
This pilot study suggests that the use of UA-ADRCs in subjects with sPTRCT is safe and leads to improved shoulder function without adverse effects. To verify the results of this initial safety and feasibility pilot study in a larger patient population, a randomized controlled trial on 246 patients suffering from sPTRCT is currently ongoing.
Clinicaltrials.gov ID NCT02918136. Registered September 28, 2016, https://clinicaltrials.gov/ct2/show/NCT02918136.
Level I; prospective, randomized, controlled trial. This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated from lipoaspirate at the point of care is safe and more effective than corticosteroid injection. Subjects aged between 30 and 75 years with sPTRCT who did not respond to physical therapy treatments for at least 6 weeks were randomly assigned to receive a single injection of an average 11.4 x 10.sup.6 UA-ADRCs (in 5 mL liquid; mean cell viability: 88%) (n = 11; modified intention-to-treat (mITT) population) or a single injection of 80 mg of methylprednisolone (40 mg/mL; 2 mL) plus 3 mL of 0.25% bupivacaine (n = 5; mITT population), respectively. Safety and efficacy were assessed using the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES), RAND Short Form-36 Health Survey, and pain visual analogue scale (VAS) at baseline (BL) as well as 3 weeks (W3), W6, W9, W12, W24, W32, W40, and W52 post treatment. Fat-saturated T2-weighted magnetic resonance imaging of the shoulder was performed at BL as well as at W24 and W52 post treatment. No severe adverse events related to the injection of UA-ADRCs were observed in the 12 months post treatment. The risks connected with treatment of sPTRCT with UA-ADRCs were not greater than those connected with treatment of sPTRCT with corticosteroid injection. However, one subject in the corticosteroid group developed a full rotator cuff tear during the course of this pilot study. Despite the small number of subjects in this pilot study, those in the UA-ADRCs group showed statistically significantly higher mean ASES total scores at W24 and W52 post treatment than those in the corticosteroid group (p < 0.05). This pilot study suggests that the use of UA-ADRCs in subjects with sPTRCT is safe and leads to improved shoulder function without adverse effects. To verify the results of this initial safety and feasibility pilot study in a larger patient population, a randomized controlled trial on 246 patients suffering from sPTRCT is currently ongoing. This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated from lipoaspirate at the point of care is safe and more effective than corticosteroid injection.BACKGROUNDThis study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated from lipoaspirate at the point of care is safe and more effective than corticosteroid injection.Subjects aged between 30 and 75 years with sPTRCT who did not respond to physical therapy treatments for at least 6 weeks were randomly assigned to receive a single injection of an average 11.4 × 106 UA-ADRCs (in 5 mL liquid; mean cell viability: 88%) (n = 11; modified intention-to-treat (mITT) population) or a single injection of 80 mg of methylprednisolone (40 mg/mL; 2 mL) plus 3 mL of 0.25% bupivacaine (n = 5; mITT population), respectively. Safety and efficacy were assessed using the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES), RAND Short Form-36 Health Survey, and pain visual analogue scale (VAS) at baseline (BL) as well as 3 weeks (W3), W6, W9, W12, W24, W32, W40, and W52 post treatment. Fat-saturated T2-weighted magnetic resonance imaging of the shoulder was performed at BL as well as at W24 and W52 post treatment.METHODSSubjects aged between 30 and 75 years with sPTRCT who did not respond to physical therapy treatments for at least 6 weeks were randomly assigned to receive a single injection of an average 11.4 × 106 UA-ADRCs (in 5 mL liquid; mean cell viability: 88%) (n = 11; modified intention-to-treat (mITT) population) or a single injection of 80 mg of methylprednisolone (40 mg/mL; 2 mL) plus 3 mL of 0.25% bupivacaine (n = 5; mITT population), respectively. Safety and efficacy were assessed using the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES), RAND Short Form-36 Health Survey, and pain visual analogue scale (VAS) at baseline (BL) as well as 3 weeks (W3), W6, W9, W12, W24, W32, W40, and W52 post treatment. Fat-saturated T2-weighted magnetic resonance imaging of the shoulder was performed at BL as well as at W24 and W52 post treatment.No severe adverse events related to the injection of UA-ADRCs were observed in the 12 months post treatment. The risks connected with treatment of sPTRCT with UA-ADRCs were not greater than those connected with treatment of sPTRCT with corticosteroid injection. However, one subject in the corticosteroid group developed a full rotator cuff tear during the course of this pilot study. Despite the small number of subjects in this pilot study, those in the UA-ADRCs group showed statistically significantly higher mean ASES total scores at W24 and W52 post treatment than those in the corticosteroid group (p < 0.05).RESULTSNo severe adverse events related to the injection of UA-ADRCs were observed in the 12 months post treatment. The risks connected with treatment of sPTRCT with UA-ADRCs were not greater than those connected with treatment of sPTRCT with corticosteroid injection. However, one subject in the corticosteroid group developed a full rotator cuff tear during the course of this pilot study. Despite the small number of subjects in this pilot study, those in the UA-ADRCs group showed statistically significantly higher mean ASES total scores at W24 and W52 post treatment than those in the corticosteroid group (p < 0.05).This pilot study suggests that the use of UA-ADRCs in subjects with sPTRCT is safe and leads to improved shoulder function without adverse effects. To verify the results of this initial safety and feasibility pilot study in a larger patient population, a randomized controlled trial on 246 patients suffering from sPTRCT is currently ongoing.DISCUSSIONThis pilot study suggests that the use of UA-ADRCs in subjects with sPTRCT is safe and leads to improved shoulder function without adverse effects. To verify the results of this initial safety and feasibility pilot study in a larger patient population, a randomized controlled trial on 246 patients suffering from sPTRCT is currently ongoing.Clinicaltrials.gov ID NCT02918136. Registered September 28, 2016, https://clinicaltrials.gov/ct2/show/NCT02918136.TRIAL REGISTRATIONClinicaltrials.gov ID NCT02918136. Registered September 28, 2016, https://clinicaltrials.gov/ct2/show/NCT02918136.Level I; prospective, randomized, controlled trial.LEVEL OF EVIDENCELevel I; prospective, randomized, controlled trial. Background This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated from lipoaspirate at the point of care is safe and more effective than corticosteroid injection. Methods Subjects aged between 30 and 75 years with sPTRCT who did not respond to physical therapy treatments for at least 6 weeks were randomly assigned to receive a single injection of an average 11.4 × 10 6 UA-ADRCs (in 5 mL liquid; mean cell viability: 88%) ( n = 11; modified intention-to-treat (mITT) population) or a single injection of 80 mg of methylprednisolone (40 mg/mL; 2 mL) plus 3 mL of 0.25% bupivacaine ( n = 5; mITT population), respectively. Safety and efficacy were assessed using the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES), RAND Short Form-36 Health Survey, and pain visual analogue scale (VAS) at baseline (BL) as well as 3 weeks (W3), W6, W9, W12, W24, W32, W40, and W52 post treatment. Fat-saturated T2-weighted magnetic resonance imaging of the shoulder was performed at BL as well as at W24 and W52 post treatment. Results No severe adverse events related to the injection of UA-ADRCs were observed in the 12 months post treatment. The risks connected with treatment of sPTRCT with UA-ADRCs were not greater than those connected with treatment of sPTRCT with corticosteroid injection. However, one subject in the corticosteroid group developed a full rotator cuff tear during the course of this pilot study. Despite the small number of subjects in this pilot study, those in the UA-ADRCs group showed statistically significantly higher mean ASES total scores at W24 and W52 post treatment than those in the corticosteroid group ( p < 0.05). Discussion This pilot study suggests that the use of UA-ADRCs in subjects with sPTRCT is safe and leads to improved shoulder function without adverse effects. To verify the results of this initial safety and feasibility pilot study in a larger patient population, a randomized controlled trial on 246 patients suffering from sPTRCT is currently ongoing. Trial registration Clinicaltrials.gov ID NCT02918136. Registered September 28, 2016, https://clinicaltrials.gov/ct2/show/NCT02918136 . Level of evidence Level I; prospective, randomized, controlled trial. Background This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated from lipoaspirate at the point of care is safe and more effective than corticosteroid injection. Methods Subjects aged between 30 and 75 years with sPTRCT who did not respond to physical therapy treatments for at least 6 weeks were randomly assigned to receive a single injection of an average 11.4 x 10.sup.6 UA-ADRCs (in 5 mL liquid; mean cell viability: 88%) (n = 11; modified intention-to-treat (mITT) population) or a single injection of 80 mg of methylprednisolone (40 mg/mL; 2 mL) plus 3 mL of 0.25% bupivacaine (n = 5; mITT population), respectively. Safety and efficacy were assessed using the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES), RAND Short Form-36 Health Survey, and pain visual analogue scale (VAS) at baseline (BL) as well as 3 weeks (W3), W6, W9, W12, W24, W32, W40, and W52 post treatment. Fat-saturated T2-weighted magnetic resonance imaging of the shoulder was performed at BL as well as at W24 and W52 post treatment. Results No severe adverse events related to the injection of UA-ADRCs were observed in the 12 months post treatment. The risks connected with treatment of sPTRCT with UA-ADRCs were not greater than those connected with treatment of sPTRCT with corticosteroid injection. However, one subject in the corticosteroid group developed a full rotator cuff tear during the course of this pilot study. Despite the small number of subjects in this pilot study, those in the UA-ADRCs group showed statistically significantly higher mean ASES total scores at W24 and W52 post treatment than those in the corticosteroid group (p < 0.05). Discussion This pilot study suggests that the use of UA-ADRCs in subjects with sPTRCT is safe and leads to improved shoulder function without adverse effects. To verify the results of this initial safety and feasibility pilot study in a larger patient population, a randomized controlled trial on 246 patients suffering from sPTRCT is currently ongoing. Trial registration Clinicaltrials.gov ID NCT02918136. Registered September 28, 2016, Level of evidence Level I; prospective, randomized, controlled trial. Keywords: Adipose-derived regenerative cells (ADRCs), Partial rotator cuff tear, Point of care treatment, Safety, Shoulder disease, Stem cells, Stromal vascular fraction Abstract Background This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated from lipoaspirate at the point of care is safe and more effective than corticosteroid injection. Methods Subjects aged between 30 and 75 years with sPTRCT who did not respond to physical therapy treatments for at least 6 weeks were randomly assigned to receive a single injection of an average 11.4 × 106 UA-ADRCs (in 5 mL liquid; mean cell viability: 88%) (n = 11; modified intention-to-treat (mITT) population) or a single injection of 80 mg of methylprednisolone (40 mg/mL; 2 mL) plus 3 mL of 0.25% bupivacaine (n = 5; mITT population), respectively. Safety and efficacy were assessed using the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES), RAND Short Form-36 Health Survey, and pain visual analogue scale (VAS) at baseline (BL) as well as 3 weeks (W3), W6, W9, W12, W24, W32, W40, and W52 post treatment. Fat-saturated T2-weighted magnetic resonance imaging of the shoulder was performed at BL as well as at W24 and W52 post treatment. Results No severe adverse events related to the injection of UA-ADRCs were observed in the 12 months post treatment. The risks connected with treatment of sPTRCT with UA-ADRCs were not greater than those connected with treatment of sPTRCT with corticosteroid injection. However, one subject in the corticosteroid group developed a full rotator cuff tear during the course of this pilot study. Despite the small number of subjects in this pilot study, those in the UA-ADRCs group showed statistically significantly higher mean ASES total scores at W24 and W52 post treatment than those in the corticosteroid group (p < 0.05). Discussion This pilot study suggests that the use of UA-ADRCs in subjects with sPTRCT is safe and leads to improved shoulder function without adverse effects. To verify the results of this initial safety and feasibility pilot study in a larger patient population, a randomized controlled trial on 246 patients suffering from sPTRCT is currently ongoing. Trial registration Clinicaltrials.gov ID NCT02918136. Registered September 28, 2016, https://clinicaltrials.gov/ct2/show/NCT02918136 . Level of evidence Level I; prospective, randomized, controlled trial. Background This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated from lipoaspirate at the point of care is safe and more effective than corticosteroid injection. Methods Subjects aged between 30 and 75 years with sPTRCT who did not respond to physical therapy treatments for at least 6 weeks were randomly assigned to receive a single injection of an average 11.4 × 106 UA-ADRCs (in 5 mL liquid; mean cell viability: 88%) (n = 11; modified intention-to-treat (mITT) population) or a single injection of 80 mg of methylprednisolone (40 mg/mL; 2 mL) plus 3 mL of 0.25% bupivacaine (n = 5; mITT population), respectively. Safety and efficacy were assessed using the American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES), RAND Short Form-36 Health Survey, and pain visual analogue scale (VAS) at baseline (BL) as well as 3 weeks (W3), W6, W9, W12, W24, W32, W40, and W52 post treatment. Fat-saturated T2-weighted magnetic resonance imaging of the shoulder was performed at BL as well as at W24 and W52 post treatment. Results No severe adverse events related to the injection of UA-ADRCs were observed in the 12 months post treatment. The risks connected with treatment of sPTRCT with UA-ADRCs were not greater than those connected with treatment of sPTRCT with corticosteroid injection. However, one subject in the corticosteroid group developed a full rotator cuff tear during the course of this pilot study. Despite the small number of subjects in this pilot study, those in the UA-ADRCs group showed statistically significantly higher mean ASES total scores at W24 and W52 post treatment than those in the corticosteroid group (p < 0.05). Discussion This pilot study suggests that the use of UA-ADRCs in subjects with sPTRCT is safe and leads to improved shoulder function without adverse effects. To verify the results of this initial safety and feasibility pilot study in a larger patient population, a randomized controlled trial on 246 patients suffering from sPTRCT is currently ongoing. Trial registration Clinicaltrials.gov ID NCT02918136. Registered September 28, 2016, https://clinicaltrials.gov/ct2/show/NCT02918136. Level of evidence Level I; prospective, randomized, controlled trial. |
| ArticleNumber | 122 |
| Audience | Academic |
| Author | Facile, Tiffany R. Maffulli, Nicola Alt, Christopher Weiss, Jennifer Hayes, Meredith Schmitz, Christoph Hayes, Matthew Alt, Eckhard U. Hurd, Jason L. Furia, John P. Winnier, Glenn E. Lundeen, Mark |
| Author_xml | – sequence: 1 givenname: Jason L. surname: Hurd fullname: Hurd, Jason L. email: Jason.Hurd@SanfordHealth.org organization: Sanford Orthopedics & Sports Medicine Sioux Falls – sequence: 2 givenname: Tiffany R. surname: Facile fullname: Facile, Tiffany R. organization: Sanford Health – sequence: 3 givenname: Jennifer surname: Weiss fullname: Weiss, Jennifer organization: Sanford Health – sequence: 4 givenname: Matthew surname: Hayes fullname: Hayes, Matthew organization: Sanford Radiology Clinic – sequence: 5 givenname: Meredith surname: Hayes fullname: Hayes, Meredith organization: Sanford Radiology Clinic – sequence: 6 givenname: John P. surname: Furia fullname: Furia, John P. organization: SUN Orthopedics of Evangelical Community Hospital – sequence: 7 givenname: Nicola surname: Maffulli fullname: Maffulli, Nicola organization: Department of Musculoskeletal Disorders, Faculty of Medicine and Surgery, University of Salerno, Centre for Sports and Exercise Medicine, Barts and The London School of Medicine and Dentistry, Mile End Hospital, Queen Mary University of London, School of Pharmacy and Bioengineering, Guy Hilton Research Centre, Keele University School of Medicine – sequence: 8 givenname: Glenn E. surname: Winnier fullname: Winnier, Glenn E. organization: InGeneron, Inc – sequence: 9 givenname: Christopher surname: Alt fullname: Alt, Christopher organization: InGeneron GmbH – sequence: 10 givenname: Christoph surname: Schmitz fullname: Schmitz, Christoph organization: Institute of Anatomy, Faculty of Medicine, LMU Munich – sequence: 11 givenname: Eckhard U. surname: Alt fullname: Alt, Eckhard U. organization: Sanford Health, InGeneron, Inc., Isar Klinikum – sequence: 12 givenname: Mark surname: Lundeen fullname: Lundeen, Mark organization: Sanford Orthopedics & Sports Medicine Fargo |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32238172$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNU01v1DAUDKgI2gI_gAOyxKVITbHjZJNwQFqVr0qVkIBK3Ky39vOuS2IH22m1_HqcbumXUEVyyIszM_abN9nJtqyzmGUvGD1grJm9CYxT1uS0oDllM87y5mG2zeqyzeu2_bF1o36S7YRwSmlFq6Z8nD3hRcEbVhfbD55_A41xTcAqglobCXJNnCbRI0RjlySs-yG6Pr3IfTKAjwa6PK6M_GkxBOJdhOg8kaNOJAQfyLmJK6I9htU-Ga0cuzh6VFPdO2W0mWoYo-vc0o2BgDKDC5gr9OYMFfG4RIs-bXiGRGLXBbJ3Ms_n778ehtfEBNdBTDCIJK6QDM7YOB1Ygse3BMjgXRhQTux94lNbrje_py2ls9G7rktcbXyIubH5auzBksF0LpIQR7V-mj3S0AV8dvnczU4-fvh--Dk__vLp6HB-nMsZrWMOtWZQM0ap4po2Zd2CVJxKLErecqrbJtUtLbQqJJ1hoxQtJZasBZC8bhXfzY42usrBqRi86cGvhQMjLhacX4rJatmhqLAtuK4VwIKVvKigbheLRVKfcd3wdO1mfKM12gHW59B1V4KMiikpYpMUkZIiLpIimsR6t2EN46JHJTG5A92to9z-Ys1KLN2ZmNquWZUE9i4FvPs1YoiiN2GaF1hMcxUpYVXNS1azBH11B3rqRm-TwQnVspLytqquUUtIbRurXdpXTqJiPitqXvCynCXUwT9Q6VbYmzRj1Cat3yK8vNnoVYd__4EEaDYAmaITPGohTQq1mfICprvfxOIO9b-cv5xXSGC7RH_txj2sP8jYP2w |
| CitedBy_id | crossref_primary_10_3390_jcm12144719 crossref_primary_10_2147_ORR_S348726 crossref_primary_10_1016_j_lfs_2024_122761 crossref_primary_10_1016_j_eats_2025_103470 crossref_primary_10_1016_j_xrrt_2024_12_003 crossref_primary_10_1186_s13018_022_03305_z crossref_primary_10_1186_s40634_022_00520_9 crossref_primary_10_3390_cells12010030 crossref_primary_10_3390_ijms221910586 crossref_primary_10_2217_rme_2021_0166 crossref_primary_10_3390_pharmaceutics15071873 crossref_primary_10_2106_JBJS_RVW_24_00063 crossref_primary_10_1016_j_csm_2022_08_002 crossref_primary_10_4252_wjsc_v13_i7_944 crossref_primary_10_1080_14712598_2021_1928630 crossref_primary_10_1016_j_arthro_2024_03_035 crossref_primary_10_1007_s11678_022_00699_4 crossref_primary_10_1097_MD_0000000000024965 crossref_primary_10_3390_ijms25063139 crossref_primary_10_1038_s41598_023_46653_4 crossref_primary_10_1186_s13287_022_02739_w crossref_primary_10_1302_0301_620X_106B9_BJJ_2024_0513_R1 crossref_primary_10_1186_s12891_023_06756_5 crossref_primary_10_2217_rme_2020_0068 crossref_primary_10_3390_medicina59020273 crossref_primary_10_2519_jospt_2025_13182 crossref_primary_10_4055_jkoa_2023_58_6_452 crossref_primary_10_1186_s13018_024_05396_2 crossref_primary_10_1177_03635465221083324 crossref_primary_10_13105_wjma_v10_i3_162 crossref_primary_10_3390_jpm13030436 crossref_primary_10_7759_cureus_59970 crossref_primary_10_1016_j_jisako_2024_05_007 crossref_primary_10_1186_s13287_024_03703_6 crossref_primary_10_1016_j_tice_2025_102836 crossref_primary_10_1016_S1615_9071_21_00114_3 crossref_primary_10_3390_bioengineering7030086 crossref_primary_10_5435_JAAOS_D_20_01092 crossref_primary_10_1126_scitranslmed_abl8814 crossref_primary_10_1097_JSA_0000000000000350 crossref_primary_10_1016_j_jot_2023_07_006 crossref_primary_10_1186_s13018_022_02918_8 crossref_primary_10_1080_14712598_2020_1786532 crossref_primary_10_3390_cells10092303 crossref_primary_10_1080_14712598_2022_2016695 crossref_primary_10_3389_fbioe_2022_866195 crossref_primary_10_3390_cells9051097 |
| Cites_doi | 10.1016/S0140-6736(17)31366-1 10.1097/00003086-199005000-00010 10.1177/0363546517751397 10.11138/mltj/2013.3.2.070 10.7326/M17-0046 10.1053/j.gastro.2008.11.041 10.1177/2325967118805731 10.1155/2015/458786 10.1371/journal.pone.0221457 10.1097/SAP.0000000000000831 10.1002/jor.22193 10.1007/s00167-013-2560-6 10.1097/JSA.0000000000000191 10.1016/j.arthro.2019.02.009 10.1097/00005650-199206000-00002 10.1302/0301-620X.96B1.32168 10.1016/j.jse.2015.07.035 10.1002/hec.4730020305 10.1007/s00264-014-2391-1 10.1177/0363546517702863 10.4252/wjsc.v11.i10.831 10.1155/2013/383685 10.1177/0363546513512770 10.1016/j.bbrc.2007.09.058 10.1177/036354659702500305 10.1177/0363546519851097 10.1016/j.sder.2006.06.006 10.5312/wjo.v5.i5.623 10.1097/00006534-199311000-00014 10.1007/s11307-010-0392-z 10.1016/j.arthro.2018.10.115 10.1177/0363546505280213 10.1177/2325967116636586 10.1016/j.jse.2014.09.031 10.1016/S0140-6736(10)61160-9 10.55095/achot2015/034 10.1007/s00590-019-02366-x 10.1186/s13018-019-1207-9 10.1016/j.arthro.2019.12.006 10.1177/0363546513496214 10.1002/stem.2855 10.2106/00004623-199501000-00002 10.1177/0269215516634815 10.4252/wjsc.v11.i2.124 10.1177/2050312116671725 10.1016/j.recot.2017.03.001 10.1007/s00167-011-1607-9 10.1302/0301-620X.46B2.314 10.1002/acr.20630 10.1007/s00264-013-1952-z 10.1016/j.jse.2018.11.051 10.3109/14397595.2013.857798 10.1016/S0020-1383(14)70006-3 10.7326/0003-4819-158-3-201302050-00583 10.1016/j.arthro.2014.09.007 10.3727/096368915X686968 10.1007/s00264-015-2937-x 10.1177/0363546513499138 10.1097/00003086-198303000-00010 10.1067/mse.2000.101959 10.1177/0363546509332505 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2020 COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2020 – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTOC UNPAY DOA |
| DOI | 10.1186/s13018-020-01631-8 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Physical Therapy |
| EISSN | 1749-799X |
| EndPage | 18 |
| ExternalDocumentID | oai_doaj_org_article_5e923f7daab14325a79bbbe9063f8333 10.1186/s13018-020-01631-8 PMC7110715 A627323446 32238172 10_1186_s13018_020_01631_8 |
| Genre | Randomized Controlled Trial Multicenter Study Journal Article |
| GeographicLocations | United States--US |
| GeographicLocations_xml | – name: United States--US |
| GrantInformation_xml | – fundername: InGeneron, Inc. grantid: N/A – fundername: Sanford Health grantid: N/A – fundername: ; grantid: N/A |
| GroupedDBID | --- 0R~ 29L 2WC 53G 5GY 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACPRK ACUHS ADBBV ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EBD EBLON EBS EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR IPT ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TUS UKHRP WOQ WOW ~8M AAYXX CITATION ALIPV CGR CUY CVF ECM EIF NPM PMFND 3V. 7QP 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM 2VQ 4.4 ADTOC AHSBF EJD H13 IPNFZ RIG UNPAY |
| ID | FETCH-LOGICAL-c607t-a7f1a71100d3f08479acd30ce243930f980ce902fd2c06e8dd04ce419aac379d3 |
| IEDL.DBID | M48 |
| ISSN | 1749-799X |
| IngestDate | Wed Aug 27 01:29:21 EDT 2025 Wed Oct 01 15:48:47 EDT 2025 Tue Sep 30 16:20:05 EDT 2025 Fri Sep 05 07:07:47 EDT 2025 Fri Jul 25 21:39:27 EDT 2025 Tue Jun 17 21:25:48 EDT 2025 Tue Jun 10 20:39:09 EDT 2025 Thu Apr 03 07:01:14 EDT 2025 Thu Apr 24 23:07:20 EDT 2025 Wed Oct 01 02:58:30 EDT 2025 Sat Sep 06 07:24:38 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Adipose-derived regenerative cells (ADRCs) Shoulder disease Stem cells Safety Stromal vascular fraction Partial rotator cuff tear Point of care treatment |
| Language | English |
| License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. cc-by |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c607t-a7f1a71100d3f08479acd30ce243930f980ce902fd2c06e8dd04ce419aac379d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s13018-020-01631-8 |
| PMID | 32238172 |
| PQID | 2391403955 |
| PQPubID | 55349 |
| PageCount | 18 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_5e923f7daab14325a79bbbe9063f8333 unpaywall_primary_10_1186_s13018_020_01631_8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7110715 proquest_miscellaneous_2385734171 proquest_journals_2391403955 gale_infotracmisc_A627323446 gale_infotracacademiconefile_A627323446 pubmed_primary_32238172 crossref_citationtrail_10_1186_s13018_020_01631_8 crossref_primary_10_1186_s13018_020_01631_8 springer_journals_10_1186_s13018_020_01631_8 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-03-30 |
| PublicationDateYYYYMMDD | 2020-03-30 |
| PublicationDate_xml | – month: 03 year: 2020 text: 2020-03-30 day: 30 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Journal of orthopaedic surgery and research |
| PublicationTitleAbbrev | J Orthop Surg Res |
| PublicationTitleAlternate | J Orthop Surg Res |
| PublicationYear | 2020 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | JL Ellera Gomes (1631_CR52) 2012; 20 1631_CR68 HS Chen (1631_CR21) 2015; 24 CJ Fu (1631_CR63) 2017; 31 JP Gumucio (1631_CR22) 2016; 40 L Lins (1631_CR42) 2016; 4 JD Wylie (1631_CR41) 2014; 5 W Ben Kibler (1631_CR33) 2009; 37 AG Via (1631_CR2) 2013; 3 S Sadat (1631_CR49) 2007; 363 G Cossu (1631_CR57) 2018; 391 I Boutron (1631_CR31) 2017; 167 JA Klein (1631_CR37) 1993; 92 H Ellman (1631_CR4) 1990; 254 AA Leto Barone (1631_CR51) 2013; 2013 N Taniguchi (1631_CR59) 2015; 24 1631_CR9 1631_CR15 1631_CR12 GE Winnier (1631_CR28) 2019; 14 P Hernigou (1631_CR53) 2014; 38 EU Alt (1631_CR27) 2020 LZ Payne (1631_CR8) 1997; 25 L Osti (1631_CR60) 2011; 37 Ö Solakoglu (1631_CR29) 2019; 11 ET Hurley (1631_CR65) 2019; 47 RJ Warth (1631_CR62) 2015; 31 RE Cotton (1631_CR5) 1964; 46B M Valencia Mora (1631_CR20) 2014; 45 H Fukuda (1631_CR6) 2000; 9 V Havlas (1631_CR54) 2015; 82 YS Kim (1631_CR55) 2017; 45 WP Coleman 4th (1631_CR36) 2006; 25 1631_CR47 SH Kim (1631_CR19) 2014; 22 D Tsekes (1631_CR23) 2019; 29 JA Coory (1631_CR69) 2019; 28 1631_CR45 1631_CR43 1631_CR44 I Andia (1631_CR24) 2018; 26 J Ware (1631_CR38) 1992; 30 LM Jazrawi (1631_CR66) 2019; 35 KC Kim (1631_CR18) 2014; 42 1631_CR40 J Ramírez (1631_CR14) 2014; 24 JA Aronowitz (1631_CR46) 2016; 77 ET Hurley (1631_CR25) 2019; 35 J Kukkonen (1631_CR16) 2014; 96-B AW Chan (1631_CR32) 2013; 158 SJ Kim (1631_CR17) 2013; 41 A Haenel (1631_CR30) 2019; 11 1631_CR34 1631_CR35 X Bai (1631_CR48) 2011; 13 G Matthewson (1631_CR3) 2015; 2015 CH Jo (1631_CR56) 2018; 36 JX Checketts (1631_CR10) 2018; 6 RD Hays (1631_CR39) 1993; 2 BK Coombes (1631_CR11) 2010; 376 YZ Cai (1631_CR61) 2015; 24 MA González (1631_CR50) 2009; 136 MJ Matava (1631_CR1) 2005; 33 JS Sher (1631_CR7) 1995; 77 I Miranda (1631_CR64) 2017; 61 C Han (1631_CR67) 2019; 14 CH Jo (1631_CR58) 2013; 41 J Zhang (1631_CR13) 2013; 31 AJ Schwitzguebel (1631_CR26) 2019; 47 |
| References_xml | – volume: 391 start-page: 883 issue: 10123 year: 2018 ident: 1631_CR57 publication-title: Lancet. doi: 10.1016/S0140-6736(17)31366-1 – volume: 254 start-page: 64 year: 1990 ident: 1631_CR4 publication-title: Clin Orthop Relat Res. doi: 10.1097/00003086-199005000-00010 – volume: 47 start-page: 753 issue: 3 year: 2019 ident: 1631_CR65 publication-title: Am J Sports Med. doi: 10.1177/0363546517751397 – volume: 3 start-page: 70 issue: 2 year: 2013 ident: 1631_CR2 publication-title: Muscles Ligaments Tendons J doi: 10.11138/mltj/2013.3.2.070 – volume: 167 start-page: 40 issue: 1 year: 2017 ident: 1631_CR31 publication-title: Ann Intern Med. doi: 10.7326/M17-0046 – volume: 136 start-page: 978 issue: 3 year: 2009 ident: 1631_CR50 publication-title: Gastroenterology. doi: 10.1053/j.gastro.2008.11.041 – volume: 6 start-page: 232596711880573 issue: 11 year: 2018 ident: 1631_CR10 publication-title: Orthop J Sports Med. doi: 10.1177/2325967118805731 – volume: 2015 start-page: 458786 year: 2015 ident: 1631_CR3 publication-title: Adv Orthop. doi: 10.1155/2015/458786 – volume: 14 issue: 9 year: 2019 ident: 1631_CR28 publication-title: PLoS One. doi: 10.1371/journal.pone.0221457 – volume: 77 start-page: 354 issue: 3 year: 2016 ident: 1631_CR46 publication-title: Ann Plast Surg. doi: 10.1097/SAP.0000000000000831 – ident: 1631_CR9 – volume-title: Bioethics and research on adult stem cells year: 2020 ident: 1631_CR27 – volume: 31 start-page: 105 issue: 1 year: 2013 ident: 1631_CR13 publication-title: J Orthop Res. doi: 10.1002/jor.22193 – volume: 22 start-page: 2867 issue: 11 year: 2014 ident: 1631_CR19 publication-title: Knee Surg Sports Traumatol Arthrosc. doi: 10.1007/s00167-013-2560-6 – volume: 26 start-page: 59 issue: 2 year: 2018 ident: 1631_CR24 publication-title: Sports Med Arthrosc Rev. doi: 10.1097/JSA.0000000000000191 – volume: 35 start-page: 1592 issue: 5 year: 2019 ident: 1631_CR66 publication-title: Arthroscopy. doi: 10.1016/j.arthro.2019.02.009 – volume: 30 start-page: 473 issue: 6 year: 1992 ident: 1631_CR38 publication-title: Med Care doi: 10.1097/00005650-199206000-00002 – volume: 96-B start-page: 75 issue: 1 year: 2014 ident: 1631_CR16 publication-title: Bone Joint J. doi: 10.1302/0301-620X.96B1.32168 – volume: 24 start-page: 1852 issue: 12 year: 2015 ident: 1631_CR61 publication-title: J Shoulder Elbow Surg. doi: 10.1016/j.jse.2015.07.035 – volume: 2 start-page: 217 issue: 3 year: 1993 ident: 1631_CR39 publication-title: Health Econ doi: 10.1002/hec.4730020305 – volume: 38 start-page: 1811 issue: 9 year: 2014 ident: 1631_CR53 publication-title: Int Orthop. doi: 10.1007/s00264-014-2391-1 – volume: 45 start-page: 2010 issue: 9 year: 2017 ident: 1631_CR55 publication-title: Am J Sports Med. doi: 10.1177/0363546517702863 – ident: 1631_CR12 – volume: 11 start-page: 831 issue: 10 year: 2019 ident: 1631_CR30 publication-title: World J Stem Cells. doi: 10.4252/wjsc.v11.i10.831 – volume: 2013 start-page: 383685 year: 2013 ident: 1631_CR51 publication-title: Biomed Res Int. doi: 10.1155/2013/383685 – volume: 42 start-page: 451 issue: 2 year: 2014 ident: 1631_CR18 publication-title: Am J Sports Med. doi: 10.1177/0363546513512770 – volume: 363 start-page: 674 issue: 3 year: 2007 ident: 1631_CR49 publication-title: Biochem Biophys Res Commun. doi: 10.1016/j.bbrc.2007.09.058 – volume: 25 start-page: 299 issue: 3 year: 1997 ident: 1631_CR8 publication-title: Am J Sports Med. doi: 10.1177/036354659702500305 – ident: 1631_CR47 – volume: 47 start-page: 1885 issue: 8 year: 2019 ident: 1631_CR26 publication-title: Am J Sports Med. doi: 10.1177/0363546519851097 – volume: 25 start-page: 138 year: 2006 ident: 1631_CR36 publication-title: Semin Cutan Med Surg. doi: 10.1016/j.sder.2006.06.006 – ident: 1631_CR43 – volume: 5 start-page: 623 issue: 5 year: 2014 ident: 1631_CR41 publication-title: World J Orthop. doi: 10.5312/wjo.v5.i5.623 – volume: 92 start-page: 1085 year: 1993 ident: 1631_CR37 publication-title: Plast Reconstr Surg. doi: 10.1097/00006534-199311000-00014 – volume: 13 start-page: 633 issue: 4 year: 2011 ident: 1631_CR48 publication-title: Mol Imaging Biol. doi: 10.1007/s11307-010-0392-z – volume: 35 start-page: 1584 issue: 5 year: 2019 ident: 1631_CR25 publication-title: Arthroscopy. doi: 10.1016/j.arthro.2018.10.115 – volume: 33 start-page: 1405 issue: 9 year: 2005 ident: 1631_CR1 publication-title: Am J Sports Med. doi: 10.1177/0363546505280213 – ident: 1631_CR68 doi: 10.1177/2325967116636586 – volume: 24 start-page: 860 issue: 6 year: 2015 ident: 1631_CR59 publication-title: J Shoulder Elbow Surg. doi: 10.1016/j.jse.2014.09.031 – volume: 376 start-page: 1751 issue: 9754 year: 2010 ident: 1631_CR11 publication-title: Lancet. doi: 10.1016/S0140-6736(10)61160-9 – volume: 82 start-page: 229 issue: 3 year: 2015 ident: 1631_CR54 publication-title: Acta Chir Orthop Traumatol Cech. doi: 10.55095/achot2015/034 – volume: 29 start-page: 747 issue: 4 year: 2019 ident: 1631_CR23 publication-title: Eur J Orthop Surg Traumatol. doi: 10.1007/s00590-019-02366-x – volume: 14 start-page: 183 issue: 1 year: 2019 ident: 1631_CR67 publication-title: J Orthop Surg Res. doi: 10.1186/s13018-019-1207-9 – ident: 1631_CR15 doi: 10.1016/j.arthro.2019.12.006 – volume: 41 start-page: 2041 issue: 9 year: 2013 ident: 1631_CR17 publication-title: Am J Sports Med. doi: 10.1177/0363546513496214 – volume: 36 start-page: 1441 issue: 9 year: 2018 ident: 1631_CR56 publication-title: Stem Cells. doi: 10.1002/stem.2855 – volume: 77 start-page: 10 issue: 1 year: 1995 ident: 1631_CR7 publication-title: J Bone Joint Surg Am. doi: 10.2106/00004623-199501000-00002 – ident: 1631_CR44 – volume: 31 start-page: 158 issue: 2 year: 2017 ident: 1631_CR63 publication-title: Clin Rehabil. doi: 10.1177/0269215516634815 – volume: 11 start-page: 124 issue: 2 year: 2019 ident: 1631_CR29 publication-title: World J Stem Cells. doi: 10.4252/wjsc.v11.i2.124 – volume: 4 start-page: 205031211667172 year: 2016 ident: 1631_CR42 publication-title: SAGE Open Med. doi: 10.1177/2050312116671725 – volume: 61 start-page: 249 issue: 4 year: 2017 ident: 1631_CR64 publication-title: Rev Esp Cir Ortop Traumatol. doi: 10.1016/j.recot.2017.03.001 – volume: 20 start-page: 373 issue: 2 year: 2012 ident: 1631_CR52 publication-title: Knee Surg Sports Traumatol Arthrosc. doi: 10.1007/s00167-011-1607-9 – volume: 46B start-page: 314 issue: 2 year: 1964 ident: 1631_CR5 publication-title: J Bone Joint Surg doi: 10.1302/0301-620X.46B2.314 – ident: 1631_CR40 doi: 10.1002/acr.20630 – volume: 37 start-page: 2165 issue: 11 year: 2011 ident: 1631_CR60 publication-title: Int Orthop doi: 10.1007/s00264-013-1952-z – volume: 28 start-page: 430 issue: 3 year: 2019 ident: 1631_CR69 publication-title: J Shoulder Elbow Surg. doi: 10.1016/j.jse.2018.11.051 – volume: 24 start-page: 667 issue: 4 year: 2014 ident: 1631_CR14 publication-title: Mod Rheumatol. doi: 10.3109/14397595.2013.857798 – ident: 1631_CR35 – volume: 45 start-page: S22 issue: Suppl 4 year: 2014 ident: 1631_CR20 publication-title: Injury. doi: 10.1016/S0020-1383(14)70006-3 – volume: 158 start-page: 200 issue: 3 year: 2013 ident: 1631_CR32 publication-title: Ann Intern Med. doi: 10.7326/0003-4819-158-3-201302050-00583 – volume: 31 start-page: 306 issue: 2 year: 2015 ident: 1631_CR62 publication-title: Arthroscopy. doi: 10.1016/j.arthro.2014.09.007 – volume: 24 start-page: 509 issue: 3 year: 2015 ident: 1631_CR21 publication-title: Cell Transplant. doi: 10.3727/096368915X686968 – volume: 40 start-page: 759 issue: 4 year: 2016 ident: 1631_CR22 publication-title: Int Orthop. doi: 10.1007/s00264-015-2937-x – volume: 41 start-page: 2650 issue: 11 year: 2013 ident: 1631_CR58 publication-title: Am J Sports Med. doi: 10.1177/0363546513499138 – ident: 1631_CR34 doi: 10.1097/00003086-198303000-00010 – ident: 1631_CR45 – volume: 9 start-page: 163 issue: 2 year: 2000 ident: 1631_CR6 publication-title: J Shoulder Elbow Surg. doi: 10.1067/mse.2000.101959 – volume: 37 start-page: 1840 issue: 9 year: 2009 ident: 1631_CR33 publication-title: Am J Sports Med. doi: 10.1177/0363546509332505 |
| SSID | ssj0050584 |
| Score | 2.4267502 |
| Snippet | Background
This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified,... This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified, autologous... Background This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured, unmodified,... Abstract Background This study tested the hypothesis that treatment of symptomatic, partial-thickness rotator cuff tears (sPTRCT) with fresh, uncultured,... |
| SourceID | doaj unpaywall pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 122 |
| SubjectTerms | Adipose Tissue - cytology Adipose Tissue - physiology Adipose Tissue - transplantation Adipose-derived regenerative cells (ADRCs) Adult Aged Bupivacaine Cell viability Consent Corticosteroids Elbow Feasibility studies Female Follow-Up Studies Glucocorticoids Humans Immunomodulators Injection Magnetic resonance imaging Male Medical research Medicine Medicine & Public Health Methylprednisolone Middle Aged Orthopedics Pain Partial rotator cuff tear Physical therapy Pilot Projects Point of care treatment Point-of-Care Systems Population Prospective Studies Regeneration - physiology Research Article Rotator cuff Rotator Cuff Injuries - diagnostic imaging Rotator Cuff Injuries - therapy Safety Shoulder Shoulder disease Single-Blind Method Sports medicine Stem Cell Transplantation - methods Stem cells Studies Surgery Surgical Orthopedics Tendons Transplantation, Autologous - methods Treatment Outcome |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwEDZoL4AEAvEKLGiQkABRa5O4SRxuZWG14sABqLS3yInt3Yg2iZoUVH49M04aWpAWDtys2m78-OaVjD8z9txII5QMYq5UlHO0tylP80Rzhb61zRP0KLTL8v0Yn86nH86is52rvignrKcH7hfuKDLogthEK5WjaQ8jlaR5npsUTauVQjieTzRj22Cq18Fo1uV0e0RGxkctaupAcgqV0MURAZd7Zsix9f-pk3eM0u8Jk-NX0xvs2rpq1Oa7Wix2DNPJbXZr8Chh1s_kDrtqqrtXbn5W1nQbUJUGQywRqthAbcHlleNfQrtZNl3t-Fon0NAyqAWn3PevpPtgVXcUjUOxttgJpaEFemMLFqPziwmgMXSMHUZTeVnr0pZUVmt3HW69bkHpsqlbwzVC_JvRsDLnjuGa1CvQ54IWXs5nfPbu03H7CkoUAfR6NagO0CWFpi6rjgZMmWlvQAGu1vZQ6ATQvup6Wf6gRw659gvsa0t0ZXlZcXfxIDTlou7A8efeY_OT91-OT_lw9QMvYj_puEpsoBKis9PC-mhBU1Vo4RcmRAdK-DaVWE790Oqw8GMjtfanhUGkKVWIJNXiPjuo6so8ZDgjBJzUeaykmkpRpBgT6jSUhS9NPA2kx4ItErJi4EWn6zkWmYuPZJz16MkQPZlDT4Z9Xo99mp4V5NLWbwlgY0ti9HY_IM6zAefZ33DusRcEz4z0Dg4PYdMfn8BJEoNXNovREQ0FRvceO9xrifqi2K_eAjwb9FWbhSIl4sY0ijz2bKymnpSDVxnEDbaRUYJOTxJ47EEvD-OU0CwQ1WPosWRPUvbmvF9TlReOzZx2OQnwuZOtTP0a1mVrOhnl7h-24NH_2ILH7HroVIjgwj9kB91qbZ6gS9rlT532-Qk9Aonf priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEDZQDoDE-7VQ0CAhAWKtJvEmcbigpVBVHBCCVuotcvxoI7ZJ2GRBy69nxpsNXZAqblFsK3byzcxne_KZsedWWqFkmHCl4oJjvM14VqSGK-TWrkiRURif5fsp2T-cfDyKj_oFt7ZPq1z7RO-oTa1pjXwnEhlJy2Vx_Lb5zunUKNpd7Y_QuMQuh0hVCNXp0TDhwuAuJ-sfZWSy06K_DiWnCRMSHRFyuRGMvGb_v575TGj6O21y2Du9xq4sqkYtf6rZ7Ex42rvFbvS8EqYrINxmF211h9383H8FOFiJB9y9cP2rcrZbgqoMWJKPUHoJtQOfcI5PgXZ52nS1F3IdQ0PAUjNOSfHfyCnCvO5omg564bARmkkLtJQLDqftJ2PAKOmlPKyh69PalK6ka7Xw5-TWixaUKZu6tdwg9n9YA3N77KWvye8C7SO08PJwyqfvv-y2r6BE20A6bEB1gFwVmrqsOuowpay9AQX4Atd_i44BA6-pT8tf9Mg-CX-GbV2JHJeXFfcnEkJTzuoOvLDuPXa49-Fgd5_3Z0JwnQRpx1XqQpWSzp0RLsDQmiltRKBthMxKBC6TeJ0FkTORDhIrjQkm2iIEldIizYy4z7aqurIPGY4IkShNkSipJlJoxFdmskjqQNpkEsoRC9fgyHUvmE7ndsxyP3GSSb4CVI6Ayj2gcmzzemjTrORCzq39jjA31CSpb3-jnh_nvefIY4sc3KVGqQK5bRSrNCuKAseYCCeFECP2ghCbk0PC7iFsVv9V4CBJ2iufJshQI4HT_hHb3qiJjkRvFq8xn_eOrM3_mN2IPRuKqSUl51UWcYN1ZJwiG0rDEXuwMpFhSBgvSAMyGrF0w3g2xrxZUpUnXuacvnIa4nPHazP7063z3ul4MMX_-ASPzh_0Y3Y18v5CcBFss61uvrBPkIV2xVPvan4DR5SHpQ priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1dj5QwFK26Jn4kGr8dXc01MdGN0wh0gOLbOLrZmOiDusm-kUJblzgDZGA046_33g7gjJqNvjXQQktP7z2lt6eMPTXSCCX9iCsVZhz9bcKTLNZcIbe2WYyMQrso3w_R0fHk3Ul40snk0F6Y7fV7X0YvG7SxvuQ0yUFyInwuL7CLIV6k8L1ZNOutLjpyOek3xfy13I7jcfr8f1rhLTf0e4jksE56lV1elbVaf1fz-ZYrOrzBrnccEqabTr_JzpvyFrv0vlslv33u2idlTbsGVWowJBGh8jVUFlxQOT4dmvWibisn1jqGmsCj5pwC37-S4YNl1dJUHPKVxUI4FBqg37VgcWp-Ogb0hE6uw2hKLypd2ILSauXOwq1WDShd1FVjuEZ8fzMaluaLk7cm2wq0VtDA8-Mpn775OGsOoED8I-XVoFpAPgp1VZQtVZjC0l6BAvxw_Y7QMaBz1dWi-EGv7ALt51jWFshjeVFyd-og1MW8asGJ595hx4dvP8-OeHfuA88jL265iq2vYtKy08J66D4TlWvh5SZA9iQ8m0hMJ15gdZB7kZFae5PcIMyUykWcaHGX7ZVVae4zbBGiTeosUlJNpMgTnBDqJJC5J0008eWI-T0o0rwTRaezOeapmxzJKN0AKUUgpQ5IKZZ5MZSpN5IgZ-Z-TVgbcpKct7uAKE8765CGBnm2jbVSGfLXIFRxkmUZtjESVgohRuwZITUlo4PVQ9hs9k5gI0m-K51GyEIDgVP7EdvfyYnGIt-93WM97YxVkwYiIdXGJAxH7Mlwm0pSAF5pEDeYR4YxMp7YH7F7m6ExNAl9Auk8BiMW7wyanTbv3imLUydlTr0c-_jecT-8flXrrG86HobgP3TBg_97-kN2JXB2Q3Dh7bO9drkyj5B5ttljZ3J-AopbfUE priority: 102 providerName: Springer Nature |
| Title | Safety and efficacy of treating symptomatic, partial-thickness rotator cuff tears with fresh, uncultured, unmodified, autologous adipose-derived regenerative cells (UA-ADRCs) isolated at the point of care: a prospective, randomized, controlled first-in-human pilot study |
| URI | https://link.springer.com/article/10.1186/s13018-020-01631-8 https://www.ncbi.nlm.nih.gov/pubmed/32238172 https://www.proquest.com/docview/2391403955 https://www.proquest.com/docview/2385734171 https://pubmed.ncbi.nlm.nih.gov/PMC7110715 https://josr-online.biomedcentral.com/track/pdf/10.1186/s13018-020-01631-8 https://doaj.org/article/5e923f7daab14325a79bbbe9063f8333 |
| UnpaywallVersion | publishedVersion |
| Volume | 15 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1749-799X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0050584 issn: 1749-799X databaseCode: RBZ dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Colorado Digital library customDbUrl: eissn: 1749-799X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0050584 issn: 1749-799X databaseCode: KQ8 dateStart: 20060101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1749-799X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0050584 issn: 1749-799X databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1749-799X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0050584 issn: 1749-799X databaseCode: ABDBF dateStart: 20060101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1749-799X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0050584 issn: 1749-799X databaseCode: DIK dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1749-799X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0050584 issn: 1749-799X databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1749-799X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0050584 issn: 1749-799X databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1749-799X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0050584 issn: 1749-799X databaseCode: RPM dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1749-799X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0050584 issn: 1749-799X databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1749-799X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0050584 issn: 1749-799X databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1749-799X dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0050584 issn: 1749-799X databaseCode: M48 dateStart: 20081201 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Nature HAS Fully OA customDbUrl: eissn: 1749-799X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0050584 issn: 1749-799X databaseCode: AAJSJ dateStart: 20061201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 1749-799X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0050584 issn: 1749-799X databaseCode: C6C dateStart: 20061201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1tb5RAEF77kviSaHz3tF7WxESNtwrsAYuJMdezTdOkjWm95L6RhV1aIgU8OPX89c7sAfa0afTTkWMXWHhm5hl2eJaQ51poLoXtMSndiEG8DVgQ-YpJ4NZJ5AOjUKbK99Dbmwz3p-50jbTLHTU3sLowtcP1pCaz7M2Pr4sPYPDvjcEL720FftgWDBMhIDDcZmKdbEJkchDlB8NuVgGCvRi2H85c2G8lOBkN_7899blQ9WcZZTeXeoNcm-elXHyXWXYuXO3eJrcanklHS2DcIWs6v0uuHjQz6feu3DyWia4XVOaKapSRkPGCFgk1hedwdFotzsq6MIKuA1oiwGTGsDj-CzpHOitqTNdpPE-gE5hLRfGVLk0gfT8dUIiWRtJDK9w-K1SapLgt52a93GJeUanSsqg0U2AD37SiM31iJLDR_1KcT6joy8mIjT4ejatXNAUbAVqsqKwpcFZaFmle4wVj6do7KincuPar0QGFAKyKs_QnnrIpxs-gb5IC12VpzszKhLRMs6KmRmD3Ppns7nwe77FmbQgWe5ZfM-kntvRR707xxIIQG8hYcSvWDjAsbiWBgO3AchLlxJanhVLWMNYARSlj7geKPyAbeZHrRwRGBIgUKvKkkEPB4wCSRhU4IraE9oa26BG7BUUYN8LpuH5HFpoESnjhEkghACk0QAqhz-uuT7mUDbm09TZirWuJkt_mj2J2EjYeJHQ1cPHEV1JGwHEdV_pBFEUwRo8ngnPeIy8QqSGaClwewGb5fQUMEiW-wpEHTNXhkP73yNZKS3Ao8eruFutha4-hwwNUdgxct0eedbuxJxbp5RpwA22E6wMr8u0eebg0jW5IEDdQC9LpEX_FaFbGvLonT0-N3Dk-Zd-G8w5a8_p9WZfd00Fngv_wCB7_39GfkOuO8RuccWuLbNSzuX4K7LSO-mTdn_p9sjka7R_vw-_2zuGnI_h37I375o1P3zilX2FIkbE |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwEDalPBQk7muhgJFAgFirSZzDQUJoaalaWioErdS34MROG7FNwiZLtfwofiMzztEuSBUvfYvW9joTf3M4GX9DyDMtNJfC9pmUXszA34YsjAPFJMTWaRxARKFMlu-Ov7Hnftz39hfI7-4sDKZVdjbRGGpVJPiOfMXhIVLLhZ73rvzBsGoUfl3tSmg0sNjSs2PYslVvN9dgfZ87zvqH3dUN1lYVYIlvBTWTQWrLAJnSFE8tMM6hTBS3Eu2Ab-ZWGgq4Di0nVU5i-VooZbmJBiGkTHgQKg7_e5FccrnlIld_sN9v8CCYEG53MEf4KxX4B1sw3KBBYMVtJuacn6kR8K8nOOUK_07T7L_VXiFL07yUs2M5Hp9yh-s3yLU2jqWjBng3yYLOb5Hrn9tVp7sNWcHtC1e_ylTXMypzRTXSVchkRouUmgR3mIVWs6OyLgxx7JCWCGQ5ZpiE_x2NMJ0UNb4WoMk0hUHw_CuKr45pOtHV4ZCCVzbUIVrh9VGhsjTDazk1dXmLaUWlysqi0kyBrv3Uik70gaHaRjtP8btFRV_ujdho7ctq9YpmoIsQfisqawqxMS2LLK_xhjFF7g2VFB5gdzp1SMHRq-Io-4VTtkn_YxibZhBTsyxnpgIiLbNxUVND5HuH7J0LWu6SxbzI9X0CEgHyhYp9KaQreAJ4DlXoiMQS2ndtMSB2B44oaQnasU7IODIbNeFHDaAiAFRkABXBmNf9mLKhJzmz93vEXN8TqcXND8XkIGotVeRpiPnTQEkZQyzteDII4zgGGX2eCs75gLxAxEZoAOH2ADbNOQ4QEqnEopEPEbHDXdcfkOW5nmC4kvnmDvNRazir6ETNB-Rp34wjMRkw14Ab6CO8AKKvwB6Qe42K9CKBf0LOSWdAgjnlmZN5viXPDg2tOq5yYMO8w07NTm7rrGc67FXxP5bgwdlCPyFLG7uftqPtzZ2th-SyY2wHZ9xaJov1ZKofQQRcx4-N2aHk23nbuT9dxsSH |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwEDawSQMkEL8pDDASEiBqLYmbxOGtbExjwIQYlfZmObG9RXRJ1KSg8tdz5yRlBTTBW9TYSZx8d_ddff5MyDMjDFfCj5hSYcog3iYsSWPNFHBrm8bAKLSr8j2I9iaj_aPw6Mwqflft3k9JtmsaUKWpaLYqbVsTF9FWDZ7XFwxTH6As3GfiElkXYRJB-rU-Hu8f7vfeGAK8GPWLZf7acyUgOd3-P73zmfD0e-nkcv70Krk8Lyq1-K6m0zMhavcGud5xSzpuwXCTXDTFLbLxsZs9v33h2qGypllQVWhqUDpCZQtaWuqKzeHqtF6cVk3pRFyHtEJQqSnDgviv6BDprGwwRafZ3EInMJGa4t-41ELKfjKkECGdjIfReHxa6tzmeKzmbo_ccl5TpfOqrA3TgPtvRtOZOXay1-hzKc4h1PTFZMzGO5-365c0B7sAKqypaijwVFqVedHgA2O52muqKLy4fqXokELQ1eVp_gNv2RXgT6GvzYHfsrxgbjdCWuXTsqFOVPcOmey-_bK9x7r9IFgWeXHDVGx9FaPGnebWg7CaqExzLzMBsCru2UTAceIFVgeZFxmhtTfKDMBPqYzHieZ3yVpRFuY-gREBCoVOIyXUSPAsgURRJ4HIPGGikS8GxO9BIbNOLB337JhKlzSJSLZAkgAk6YAkoc-rZZ-qlQo5t_UbxNqyJcp8ux_K2bHsvIYMDfBvG2ulUuC1QajiJE1TGGPEreCcD8hzRKpEZwSPB7Bp11TAIFHWS44jYKcBh5R_QDZXWoITyVZP91iXnROrZcATVHNMwnBAni5PY08szCsM4AbaiDAGJhT7A3KvNY3lkCBWoP5jMCDxitGsjHn1TJGfOIlz_MqxD_cd9ub167HOe6fDpQn-wyd48H9Xf0I2Pu3syg_vDt4_JFcC50I4494mWWtmc_MIyGmTPu78z08Z2Ins |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety+and+efficacy+of+treating+symptomatic%2C+partial-thickness+rotator+cuff+tears+with+fresh%2C+uncultured%2C+unmodified%2C+autologous+adipose-derived+regenerative+cells+%28UA-ADRCs%29+isolated+at+the+point+of+care%3A+a+prospective%2C+randomized%2C+controlled+first-in-human+pilot+study&rft.jtitle=Journal+of+orthopaedic+surgery+and+research&rft.au=Hurd%2C+Jason+L.&rft.au=Facile%2C+Tiffany+R.&rft.au=Weiss%2C+Jennifer&rft.au=Hayes%2C+Matthew&rft.date=2020-03-30&rft.pub=BioMed+Central&rft.eissn=1749-799X&rft.volume=15&rft.issue=1&rft_id=info:doi/10.1186%2Fs13018-020-01631-8&rft.externalDocID=10_1186_s13018_020_01631_8 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1749-799X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1749-799X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1749-799X&client=summon |